Location: Greenwich, CT
CIK: 0001596452 · Show all filings
Period: Q1 2020 (← Previous) (Next →)
Filing Date: May 15, 2020
Total Value: $253M (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value | % | Share Price | Est. Cost/Share | Unrealized @ Report Date | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|---|
| BMY | Bristol-Myers Squibb Co | 320,000 | $18.48M | 7.3% | $57.75 * | $47.20 | -6.1% | Cash Securities | 110122108 |
| COR | Humana Inc | 40,000 | $12.56M | 5.0% | $314.02 * | $74.64 | +2.1% | Cash Securities | 03073E105 |
| SNN | HCA Healthcare Inc | 135,187 | $12.15M | 4.8% | $89.85 * | $44.76 | -19.9% | Cash Securities | 83175M205 |
| INCY | Universal Health Services Inc | 115,000 | $11.39M | 4.5% | $99.08 * | $77.21 | -5.2% | Cash Securities | 45337C102 |
| UNH | UnitedHealth Group Inc | 42,500 | $10.6M | 4.2% | $249.39 * | $228.81 | -0.7% | Cash Securities | 91324P102 |
| DHR | AmerisourceBergen Corp | 115,000 | $10.18M | 4.0% | $88.50 * | $115.08 | +4.0% | Cash Securities | 235851102 |
| AZN | McKesson Corp | 75,000 | $10.14M | 4.0% | $135.27 | $40.88 | — | Cash Securities | 046353108 |
| MCK | Thermo Fisher Scientific Inc | 32,500 | $9.217M | 3.6% | $283.60 * | $140.83 | -7.5% | Cash Securities | 58155Q103 |
| BMRN | BioMarin Pharmaceutical Inc | 235,000 | $8.39M | 3.3% | $35.70 * | $84.53 | -0.0% | Cash Securities | 09061G101 |
| CNC | Cardinal Health Inc | 175,000 | $8.39M | 3.3% | $47.94 * | $54.65 | +8.7% | Cash Securities | 15135B101 |
| NVO | Boston Scientific Corp | 250,000 | $8.158M | 3.2% | $32.63 * | $59.55 | +1.1% | Cash Securities | 670100205 |
| EHC | Vertex Pharmaceuticals Inc | 32,500 | $7.733M | 3.1% | $237.94 * | $53.73 | -11.3% | Cash Securities | 29261A100 |
| HCA | Abbott Laboratories | 95,000 | $7.496M | 3.0% | $78.91 * | $122.19 | -29.7% | Cash Securities | 40412C101 |
| CI | Stryker Corp | 45,000 | $7.492M | 3.0% | $166.49 * | $160.41 | +1.1% | Cash Securities | 125523100 |
| CAH | Baxter International Inc | 90,000 | $7.307M | 2.9% | $81.19 * | $44.27 | -6.8% | Cash Securities | 14149Y108 |
| ISRG | Tenet Healthcare Corp | 485,523 | $6.992M | 2.8% | $14.40 * | $182.50 | -9.5% | Cash Securities | 46120E602 |
| SYK | Eli Lilly and Co | 50,000 | $6.936M | 2.7% | $138.72 * | $173.69 | -9.8% | Cash Securities | 863667101 |
| HUM | Danaher Corp | 50,000 | $6.921M | 2.7% | $138.42 * | $257.91 | +15.8% | Cash Securities | 444859102 |
| UHS | Hill-Rom Holdings Inc | 65,000 | $6.539M | 2.6% | $100.60 * | $124.69 | -22.6% | Cash Securities | 913903100 |
| BIIB | Biogen Inc | 20,000 | $6.328M | 2.5% | $316.40 | $277.46 | +14.0% | Cash Securities | 09062X103 |
| — | Novo Nordisk A/S | 100,000 | $6.02M | 2.4% | $60.20 | $60.20 | — | Cash Securities | 148806102 |
| MRK | Encompass Health Corp | 80,000 | $5.122M | 2.0% | $64.03 * | $49.81 | +22.9% | Cash Securities | 58933Y105 |
| ABT | Merck & Co Inc | 65,000 | $5.001M | 2.0% | $76.94 * | $46.59 | +53.0% | Cash Securities | 002824100 |
| PRGO | AbbVie Inc | 65,000 | $4.952M | 2.0% | $76.18 * | $53.64 | -10.3% | Cash Securities | G97822103 |
| REGN | Regeneron Pharmaceuticals Inc | 10,000 | $4.883M | 1.9% | $488.30 | $359.31 | +35.1% | Cash Securities | 75886F107 |
| VRTX | Cigna Corp | 25,000 | $4.43M | 1.7% | $177.20 * | $126.74 | +87.7% | Cash Securities | 92532F100 |
| LLY | Incyte Corp | 60,000 | $4.394M | 1.7% | $73.23 * | $89.43 | +45.1% | Cash Securities | 532457108 |
| SEM | Catalent Inc | 80,000 | $4.156M | 1.6% | $51.95 * | $10.94 | -32.0% | Cash Securities | 81619Q105 |
| — | Zimmer Biomet Holdings Inc | 40,000 | $4.043M | 1.6% | $101.08 | $102.99 | — | Cash Securities | 431475102 |
| CRL | DexCom Inc | 15,000 | $4.039M | 1.6% | $269.27 * | $149.98 | -15.8% | Cash Securities | 159864107 |
| BSX | Intuitive Surgical Inc | 7,500 | $3.714M | 1.5% | $495.20 * | $23.58 | +38.4% | Cash Securities | 101137107 |
| TMO | Smith & Nephew PLC | 100,000 | $3.587M | 1.4% | $35.87 * | $296.02 | -5.6% | Cash Securities | 883556102 |
| GRFS | Grifols SA | 175,000 | $3.525M | 1.4% | $20.14 | $20.65 | -2.5% | Cash Securities | 398438408 |
| ABBV | Bio-Rad Laboratories Inc | 10,000 | $3.506M | 1.4% | $350.60 * | $64.63 | -6.8% | Cash Securities | 00287Y109 |
| BAX | Anthem Inc | 15,000 | $3.406M | 1.3% | $227.07 * | $52.74 | +37.1% | Cash Securities | 071813109 |
| ZBH | Charles River Laboratories In | 20,000 | $2.524M | 1.0% | $126.20 * | $131.26 | -28.6% | Cash Securities | 98956P102 |
| THC | STERIS PLC | 17,500 | $2.449M | 1.0% | $139.94 * | $24.29 | -40.7% | Cash Securities | 88033G407 |
| STE | Perrigo Co PLC | 5,823 | $280K | 0.1% | $48.09 * | $141.94 | -6.3% | Cash Securities | G8473T100 |